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[dear editor]{.smallcaps}, Infantile haemangioma (IH) is a very common benign vascular tumour with a reported incidence of 4--10% in infants,[1](#bjd14791-bib-0001){ref-type="ref"} and no clear genetic basis described as yet.[2](#bjd14791-bib-0002){ref-type="ref"} Congenital melanocytic naevi (CMN) are benign melanocytic tumours present in 1% of newborns, which when multiple are caused by post‐zygotic mutations in the gene *NRAS* in the majority of cases,[3](#bjd14791-bib-0003){ref-type="ref"} and when single, carry various somatic mutations where causality is difficult to prove.[4](#bjd14791-bib-0004){ref-type="ref"}, [5](#bjd14791-bib-0005){ref-type="ref"}, [6](#bjd14791-bib-0006){ref-type="ref"} Melanocytic and vascular anomalies can coexist in the condition phakomatosis pigmentovascularis (PPV), and the same genetic mutation is responsible for both cutaneous lesions;[7](#bjd14791-bib-0007){ref-type="ref"} however, these do not involve either CMN or IH. Moreover, the vascular lesion in PPV is considered congenital and malformative as CMN, and not proliferative and acquired as IH.[8](#bjd14791-bib-0008){ref-type="ref"} A case series of six patients presenting with both CMN and IH has been reported previously, where the authors hypothesized that this co‐occurrence might be more common than expected by chance.[9](#bjd14791-bib-0009){ref-type="ref"}

To test this hypothesis we conducted a systematic evaluation of the presence of IH in the cohort of patients with CMN seen in our tertiary referral service over a 10‐year period between March 2006 and February 2016. All children were examined by the same physician, and data were collected prospectively. We included in this analysis only children less than 3 years of age at the examination date, as the natural history of IH is to spontaneously involute during the first few years of life.

A total of 244 patients with CMN under the age of 3 years were seen in this time period, with a mean and median age of 0·78 years and 0·53 years, respectively. Of these, 142 were females, giving the same male : female ratio of 1 : 1·4 as has previously been reported for our CMN cohort.[10](#bjd14791-bib-0010){ref-type="ref"} Fourteen patients were recorded as having an IH (5·7%), compatible with prevalence figures for the general population. Furthermore, the characteristics of those with an IH mirror those of the general population, as the male : female ratio for those with IH and CMN was 1 : 6. Table [1](#bjd14791-tbl-0001){ref-type="table-wrap"} shows the clinical characteristics of the patient cohort, comparing those with and without IH. The number of patients with CMN and IH is too small to perform a statistical comparison of the severity of CMN phenotype, but clinical phenotyping data are shown in Table [1](#bjd14791-tbl-0001){ref-type="table-wrap"}.

###### 

Clinical characteristics of patients with congenital melanocytic naevi (CMN) with and without infantile haemangioma (IH)

                                                          Patients with CMN, *n* (%)   Patients with CMN + IH, *n* (%)
  ------------------------------------------------------- ---------------------------- ---------------------------------
  Sex                                                                                  
  Female                                                  130 (56·5)                   12 (85·7)
  Male                                                    100 (43·5)                   2 (14·3)
  Total                                                   230 (100)                    14 (100)
  Projected adult size                                                                 
  \< 10 cm                                                58 (25·2)                    1 (7·1)
  10--20 cm                                               45 (19·6)                    3 (21·4)
  20--40 cm                                               52 (22·6)                    4 (28·6)
  40--60 cm                                               25 (10·9)                    3 (21·4)
  \> 60 cm                                                39 (17)                      1 (7·1)
  Multiple small or medium                                7 (3)                        2 (14·3)
  Missing                                                 4 (1·7)                      0
  Approximate total number of naevi at examination date                                
  1                                                       34 (14·8)                    0
  2--9                                                    55 (23·9)                    2 (14·3)
  10--19                                                  33 (14·3)                    2 (14·3)
  20--50                                                  33 (14·3)                    0
  50--100                                                 25 (10·9)                    0
  100--200                                                17 (7·4)                     2 (14·3)
  \> 200                                                  4 (1·7)                      1 (7·1)
  Missing                                                 29 (12·6)                    7 (50)
  Location of principal CMN                                                            
  Face                                                    17 (7·4)                     0
  Scalp                                                   21 (9·1)                     1 (7·1)
  Neck                                                    1 (0·4)                      0
  Trunk                                                   80 (34·8)                    3 (21·4)
  Limb                                                    26 (11·3)                    3 (21·4)
  Scalp, neck and trunk                                   8 (3·5)                      0
  Face and scalp                                          16 (7·0)                     0
  Multiple                                                4 (1·7)                      1 (7·1)
  Missing                                                 57 (24·8)                    6 (42·9)
  Location of haemangioma                                                              
  Face                                                                                 1 (7·1)
  Head and neck (nonfacial)                                                            0
  Trunk                                                                                6 (42·9)
  Extremity                                                                            3 (21·4)
  Missing                                                                              4 (28·6)
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This systematic study of the prevalence of IH in a cohort of patients with CMN has found no increase above that of the normal population, and a sex ratio in line with what we would expect for IH alone. This study does not support a connection at a genetic level between CMN and IH, either at germline predisposition or at somatic mutation level.
